InvestorsHub Logo
Followers 154
Posts 2652
Boards Moderated 0
Alias Born 01/29/2004

Re: tredenwater2 post# 106242

Friday, 05/26/2017 2:15:41 PM

Friday, May 26, 2017 2:15:41 PM

Post# of 463606
Anavex to be a business school case study.

As slow and disguised as corporate developments appear to be, I'm certain that big things are being arranged and are happening behind closed Anavex doors. Herr Doctor Missling and his every-growing body of drug development experts simply are not sitting around twiddling their thumbs, awaiting some external things to happen.

No, the Anavex principals have world-class status and know that at this stage the most important efforts are to get the Anavex picture framed and lighted, for eventual revelation to an appropriate corporate world, the complex of Big Pharmaceuticals, along with supportive and collaborative interest groups (Alzheimer's, Rett Syndrome, Parkinson's support groups, etc.).

All of this has to be done effectively --- and that's not (yet) in the public forum. All matters must first be arranged privately with appropriate parties --- and none of those are we retail Anavex equity investors. For now, we are not in the picture. Our days will come, when Missling et al. have constructed effective corporate collaborations and regulatory approvals.

I contend that, in time, the Anavex story --- how this company revolutionized 21st-century medicine --- will be classic and required reading at all business schools. How could a small group of scientists, with a collection of new molecules cobble together a fully-functioning new Big Phrama company that a) solves so many medical problems, b) reaps great rewards for shareholders, c) saves governments billions upon billions of dollars of health care costs, and d) improves the lives of countless individuals across the world?

All of us here get to watch this story as it slowly (but rapidly, in time) unfolds.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News